Drug intelligence / Profile preview

sildenafil + l-arginine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Sildenafil + l-arginine is a **combination drug** used primarily for the treatment of erectile dysfunction and for improvement of blood circulation. Sildenafil is a **phosphodiesterase type 5 (PDE5) inhibitor** that prevents the breakdown of cyclic guanosine monophosphate (cGMP), thus enhancing and prolonging nitric oxide-mediated vasodilation. L-arginine is a natural amino acid and the **biological precursor of nitric oxide**, which further augments cGMP pathway activity by increasing nitric oxide production, relaxing vascular smooth muscle, and improving endothelial function. Their combined use leads to additive or synergistic vasodilatory effects that enhance erectile function and may allow effective treatment with lower doses of each drug. Clinical and preclinical studies demonstrate improved efficacy for erectile dysfunction with the combination versus sildenafil alone, and confirm a favorable safety profile. Other possible applications (with clinical supervision) include support of cardiovascular function and improvement of coronary blood flow in specific surgical contexts[1][2][3][4].

Other names
sildenafil/l-arginine
02

Targets

PDE5 (Phosphodiesterase 5A)NOS1 (nNOS)

Beyond the preview

Go deeper on sildenafil + l-arginine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sildenafil + l-arginine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call